LONDON (Thomson Financial) - Hikma Pharmaceuticals PLC, the Jordan-based generics company, is to place 17 mln new ordinary shares, or almost 10 pct of its issued share capital, to reduce acquisition debts. The company said the placing will enable it to reduce borrowings incurred from its 163.6 mln usd purchase of Arab Pharmaceutical Manufacturing Company, announced in December.
